Chronic treatment with Δ-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats

被引:69
作者
Kolb, Bryan [1 ]
Gorny, Grazyna
Limebeer, Cheryl L.
Parker, Linda A.
机构
[1] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Psychol & Neurosci, Lethbridge, AB T1K 3M4, Canada
[2] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada
关键词
Delta(9)-THC; sensitization; Golgi-Cox; neuroplasticity; dendrite; dopamine; locomotion;
D O I
10.1002/syn.20313
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The potential of repeated exposure to Delta(9)-tetrahydrocannabinol (Delta(9)-THC) to produce long-lasting changes in synaptic connections in a manner similar to other drugs of abuse was evaluated in Sprague-Dawley rats. For 12 days, rats received two i.p. injections per day (8 h apart) of vehicle, a low dose of Delta(9)-THC (0.5 mg/kg), or escalating doses of Delta(9)-THC (0.5-4.0 mg/kg). Thirty days later, they were evaluated for sensitized locomotor activity (during the night cycle) for 60 min on each of three trials. Using a within-groups design, rats were tested following an injection of vehicle, 0.5 mg/kg Delta(9)-THC or 2.0 mg/kg Delta(9)-THC. The rats showed no evidence of sensitized locomotor activity in any group. Twenty-four hours after the final sensitization test, their brains were removed and then processed for Golgi-Cox staining. Prior exposure to Delta(9)-THC (both the low dose and the escalating doses) increased the length of the dendrites as well as the number of dendritic branches in the shell of the nucleus accumbens and in the medial prefrontal cortex, but not in the hippocampus, striatum, orbital frontal cortex, parietal cortex, or occipital cortex. These results are similar to those evident in brains of rats sensitized to amphetamine, and support previous findings that cannabinoids promote DA activity in the mesolimbic DA system.
引用
收藏
页码:429 / 436
页数:8
相关论文
共 49 条
[1]   Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine [J].
Arnold, JC ;
Topple, AN ;
Hunt, GE ;
McGregor, IS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (01) :9-16
[2]   Neurotrophic mechanisms in drug addiction [J].
Bolaños, CA ;
Nestler, EJ .
NEUROMOLECULAR MEDICINE, 2004, 5 (01) :69-83
[3]   Behavioural sensitization after repeated exposure to Δ9-tetrahydrocannabinol and cross-sensitization with morphine [J].
Cadoni, C ;
Pisanu, A ;
Solinas, M ;
Acquas, E ;
Di Chiara, G .
PSYCHOPHARMACOLOGY, 2001, 158 (03) :259-266
[4]   Molecular neurobiology of drug addiction [J].
Chao, J ;
Nestler, EJ .
ANNUAL REVIEW OF MEDICINE, 2004, 55 :113-132
[5]   Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats [J].
Chaperon, F ;
Soubrié, P ;
Puech, AJ ;
Thiébot, MH .
PSYCHOPHARMACOLOGY, 1998, 135 (04) :324-332
[6]   Cannabinoid receptors and reward in the rat: a conditioned place preference study [J].
Cheer, JF ;
Kendall, DA ;
Marsden, CA .
PSYCHOPHARMACOLOGY, 2000, 151 (01) :25-30
[7]  
CHEN JP, 1990, EUR J PHARMACOL, V190, P259
[8]   DELTA-9-TETRAHYDROCANNABINOL PRODUCES NALOXONE-BLOCKABLE ENHANCEMENT OF PRESYNAPTIC BASAL DOPAMINE EFFLUX IN NUCLEUS-ACCUMBENS OF CONSCIOUS, FREELY-MOVING RATS AS MEASURED BY INTRACEREBRAL MICRODIALYSIS [J].
CHEN, JP ;
PAREDES, W ;
LI, J ;
SMITH, D ;
LOWINSON, J ;
GARDNER, EL .
PSYCHOPHARMACOLOGY, 1990, 102 (02) :156-162
[9]  
COLEMAN PD, 1968, J ANAT, V102, P363
[10]   Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse [J].
Cossu, G ;
Ledent, C ;
Fattore, L ;
Imperato, A ;
Böhme, GA ;
Parmentier, M ;
Fratta, W .
BEHAVIOURAL BRAIN RESEARCH, 2001, 118 (01) :61-65